Dr. Atif Al-Amri, head of Saudi Education Ministry's Vision 2030 Realization Office 

Dr. Atif Al-Amri
Short Url
Updated 13 June 2020

Dr. Atif Al-Amri, head of Saudi Education Ministry's Vision 2030 Realization Office 

Dr. Atif Al-Amri has been head of the Vision 2030 Realization Office at the Saudi Ministry of Education since June 2019. Education Minister Dr. Hamad Al-Asheikh recently reappointed Al-Amri to the same post.

Al-Amri has also served as adviser to the education minister since January 2019, and was the director general of the planning department at the ministry between 2017 and 2018.

Al-Amri is also a professor of computer and information sciences in the software engineering department at King Saud University (KSU) in Riyadh.

He held several posts at KSU, including assistant vice rector of planning and development between 2014 and 2017.

Al-Amri was also chairman of the information systems department at the same university, a post he held for a year and a half between 2013 and 2014. Previously, he was vice chairman for six months.

Al-Amri has also been research chair of Pervasive and Mobile Computing (CPMC) at KSU since January 2011 and was the project manager of its data warehouse and quality management project between 2010 and 2014.

He received his bachelor’s and master’s degrees in information systems from the College of Computer and Information Science at KSU.

Later, he obtained his Ph.D. from the School of Information Technology and Engineering at the University of Ottawa in Canada.

His Ph.D. was in computer science and focused on multimedia-based medical applications.

He also worked as a research assistant at the same school at the University of Ottawa.

Al-Amri’s Twitter handle is @atif_alamri.

Saudi Arabia working on coronavirus vaccine with Chinese company

Updated 10 August 2020

Saudi Arabia working on coronavirus vaccine with Chinese company

JEDDAH: The third phase of a COVID-19 vaccine clinical trial is to be carried out on at least 5,000 volunteers in Saudi Arabia after clearing mid-stage tests.
In an effort to expedite vaccines against coronavirus, the Ministry of Health announced its preparedness to launch the third phase in health centers across Riyadh, Makkah and Dammam. The clinical trials come as part of a ministry agreement with the Chinese vaccine developing company CanSino.
The findings of the first randomized controlled trial, published in The Lancet, resulted in the vaccine appearing to be safe and inducing a significant immune response in the majority of recipients in the second phase.
The vaccine uses a harmless cold virus, known as adenovirus type-5 (Ad5), to carry genetic material from coronavirus into the body.The volunteers will be over the age of 18.
Ministry spokesman Dr. Mohammed Al-Abd Al-Aly told a press conference on Sunday that epidemiological analysis had shown a fluctuation in confirmed coronavirus cases, with a slight increase potentially caused by social gatherings during Eid Al-Adha that did not adhere to health protocols.

“These numbers are currently at a slight increase, but they are not a cause of major concern (at the moment) for outbreaks or clusters,” the spokesman said.
Estimates of COVID-19 patients needing critical care have decreased in the past three days and the current curve shows a 5.5 percent decrease in admissions. There are currently 1,816 patients in Saudi Arabia receiving critical care.
The Kingdom recorded 1,428 new cases on Sunday, raising the total number of infections to 288,690 since the beginning of the pandemic.
There were 1,599 new recoveries, raising the total number of recoveries to 252,039. There are currently 33,484 active cases.
Saudi Arabia recorded 37 new fatalities on Sunday, raising the coronavirus death toll to  3,167.
There have been 58,424 polymerase chain reaction tests carried out in the past 24 hours, raising the total number of tests in the Kingdom to over 3.8 million.